{"id":30,"date":"2021-05-24T11:22:17","date_gmt":"2021-05-24T11:22:17","guid":{"rendered":"https:\/\/martemyanovlab.com\/?page_id=30"},"modified":"2026-11-16T20:24:14","modified_gmt":"2026-11-17T01:24:14","slug":"research-projects","status":"publish","type":"page","link":"https:\/\/martemyanovlab.com\/index.php\/research-projects\/","title":{"rendered":"Research Projects"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><\/p>\n\n\n\n<h2 class=\"wp-block-heading has-text-align-center\" style=\"font-size:25px\"><strong><strong>G Protein Coupled Receptors Signaling Systems<\/strong><\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"alignright is-resized\"><img fetchpriority=\"high\" decoding=\"async\" width=\"1024\" height=\"979\" src=\"https:\/\/martemyanovlab.com\/wp-content\/uploads\/2021\/07\/image001-1024x979.jpeg\" alt=\"\" class=\"wp-image-1511\" style=\"aspect-ratio:1.0459756436193424;width:310px;height:auto\" srcset=\"https:\/\/martemyanovlab.com\/wp-content\/uploads\/2021\/07\/image001-1024x979.jpeg 1024w, https:\/\/martemyanovlab.com\/wp-content\/uploads\/2021\/07\/image001-300x287.jpeg 300w, https:\/\/martemyanovlab.com\/wp-content\/uploads\/2021\/07\/image001-768x734.jpeg 768w, https:\/\/martemyanovlab.com\/wp-content\/uploads\/2021\/07\/image001.jpeg 1062w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n<\/div>\n\n\n<p class=\"has-medium-font-size wp-block-paragraph\">T<span style=\"color: revert; font-weight: revert;\">he <\/span><em style=\"color: revert; font-weight: revert;\">main emphasis of research in my laboratory is on understanding the fundamental principles of signal processing by G protein coupled receptor (GPCR) systems and their pharmacology and role in disease.<\/em><span style=\"color: revert; font-weight: revert;\"> GPCRs constitute the largest family of cell surface receptors in mammalian genomes, endowing cells with an ability to sense their environment and communicate with each other. Their evolutionary success is underscored by a wide spectrum of extracellular stimuli that they detect, including light, ions, hormones, and neurotransmitters, and their versatile signaling to a vast number of intracellular targets, such as enzymes, ion channels and transcription factors. Accordingly, dysfunctions in GPCR systems are linked to many diseases. Furthermore, altering the activity of GPCRs pharmacologically often produces clinically beneficial outcomes regardless of the disease origin, and GPCRs are targeted by ~50% of current drugs. <\/span><em style=\"color: revert; font-weight: revert;\">Our research program is based on three pillars<\/em><span style=\"color: revert; font-weight: revert;\">.<\/span><br><span style=\"text-decoration: underline;\">First<\/span>, we have fully embraced the power of unbiased approaches and utilize genomic and proteomic screens as a discovery methods of choice. This serves as the prime idea-generator for much of our hypothetical thinking about GPCR organizational principles. A decade of efforts in this area convinced us that there is much \u2018dark\u2019 biology, uncovering which can transform our views on how GPCRs work.<br><span style=\"text-decoration: underline;\">Second<\/span>, we are committed to studying pertinent questions in an endogenous setting using physiologically relevant <em>in vivo<\/em> models. We extensively rely on genetic mouse models specifically designed to manipulate with GPCR systems with cell type selectivity and temporal precision. The elements that we uncover in the unbiased screens are studied in respect to their role in mouse physiology and behavior. <\/p>\n\n\n\n<p class=\"has-medium-font-size wp-block-paragraph\"><span style=\"text-decoration: underline;\">Third<\/span>, we are very curious about detailed molecular mechanisms involved in operation of the GPCR complexes. We constantly develop tools and technologies for the interrogation of protein-protein interactions and signal transmission steps, harnessing power of optical sensors. We also increasingly rely on structural biology approaches to obtain atomic level details. This allows us to probe the nuts-and-bolts of GPCR function.<\/p>\n\n\n\n<p class=\"has-white-color has-text-color has-link-color has-medium-font-size wp-elements-1 wp-block-paragraph\">space<\/p>\n\n\n\n<div class=\"wp-block-group\"><div class=\"wp-block-group__inner-container is-layout-flow wp-block-group-is-layout-flow\">\n<h3 class=\"wp-block-heading\" style=\"font-size:25px\"><strong><strong>Vision, retina and photoreceptor synapses<\/strong><\/strong><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n<\/div><\/div>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-7387b849 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:100%\"><div class=\"wp-block-image\">\n<figure class=\"alignright size-full is-resized\"><img decoding=\"async\" width=\"676\" height=\"746\" src=\"https:\/\/martemyanovlab.com\/wp-content\/uploads\/2021\/06\/Screen-Shot-2021-06-17-at-8.58.15-AM.png\" alt=\"\" class=\"wp-image-1092\" style=\"aspect-ratio:0.9053571428571429;width:439px;height:auto\" srcset=\"https:\/\/martemyanovlab.com\/wp-content\/uploads\/2021\/06\/Screen-Shot-2021-06-17-at-8.58.15-AM.png 676w, https:\/\/martemyanovlab.com\/wp-content\/uploads\/2021\/06\/Screen-Shot-2021-06-17-at-8.58.15-AM-272x300.png 272w\" sizes=\"(max-width: 676px) 100vw, 676px\" \/><\/figure>\n<\/div>\n\n\n<p class=\"has-medium-font-size wp-block-paragraph\">In the vertebrate retina communication of rod and cone photoreceptors with downstream ON bipolar neurons (ON-BC) is a critical point in the relay of a light stimulus to the brain. Here, light-induced changes in the release of neurotransmitter glutamate by photoreceptors are sensed by a GPCR, mGluR6, on postsynaptic ON-BCs. In addition to mediating synaptic communication with photoreceptors, mGluR6 is also essential for the physical synapse formation, a process that occurs with remarkable selectivity, such that ON-BCs discriminate between rods or cones. These features make photoreceptor synapses a convenient model for addressing many fundamental questions pertaining to spatio-temporal aspects of GPCR signaling and synaptic selectivity. Over the last several years, our laboratory substantially contributed to deciphering the molecular organization of this GPCR cascade while developing the \u2018signalosome\u2019 model. We are working to define the full composition and structure functional organization of the photoreceptor synaptic complex using a variety of approaches including electrophysiology, structural biology and biochemistry. We are also investigating cell biological mechanisms of photoreceptor wiring by defining synaptic selectivity code of photoreceptors by studying the role of newly identified cell adhesion molecules as we are also exploring general landscape of GPCR function in photoreceptors and other retina cell types.<\/p>\n\n\n\n<p class=\"has-white-color has-text-color has-link-color wp-elements-2 wp-block-paragraph\">space<\/p>\n<\/div>\n<\/div>\n\n\n\n<div class=\"wp-block-group\"><div class=\"wp-block-group__inner-container is-layout-flow wp-block-group-is-layout-flow\">\n<h3 class=\"wp-block-heading\" style=\"font-size:25px\"><strong><strong>Extracellular world of GPCRs and neurodevelopmental disorders<\/strong><\/strong><\/h3>\n<\/div><\/div>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-7387b849 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n<p class=\"wp-block-paragraph\"><\/p>\n<\/div>\n<\/div>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-7387b849 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-vertically-aligned-stretch is-layout-flow wp-block-column-is-layout-flow\"><div class=\"wp-block-image\">\n<figure class=\"alignright size-full is-resized\" style=\"margin-top:0;margin-right:0;margin-bottom:0;margin-left:0\"><img decoding=\"async\" width=\"1436\" height=\"1026\" src=\"https:\/\/martemyanovlab.com\/wp-content\/uploads\/2026\/11\/imagee-1.png\" alt=\"\" class=\"wp-image-4616\" style=\"aspect-ratio:1.398931218755387;width:499px;height:auto\" srcset=\"https:\/\/martemyanovlab.com\/wp-content\/uploads\/2026\/11\/imagee-1.png 1436w, https:\/\/martemyanovlab.com\/wp-content\/uploads\/2026\/11\/imagee-1-300x214.png 300w, https:\/\/martemyanovlab.com\/wp-content\/uploads\/2026\/11\/imagee-1-767x548.png 767w, https:\/\/martemyanovlab.com\/wp-content\/uploads\/2026\/11\/imagee-1-1024x732.png 1024w, https:\/\/martemyanovlab.com\/wp-content\/uploads\/2026\/11\/imagee-1-1140x814.png 1140w\" sizes=\"(max-width: 1436px) 100vw, 1436px\" \/><\/figure>\n<\/div>\n\n\n<p class=\"has-medium-font-size wp-block-paragraph\">The field has traditionally focused on cell-autonomous mechanisms of GPCR function, studying transducers of their signals, effector molecules and downstream regulators. Our proteomic profiling efforts led to an unexpected discovery that GPCRs also engage in extracellular interactions with cell-adhesion molecules that critically shape their function. We are particularly focused on the association of entire group III of metabotropic glutamate receptors (mGluR4, mGluR6, mGluR7 and mGluR8) the key presynaptic autoreceptors in the brain that regulate the release of main excitatory neurotransmitter glutamate, with cell adhesion molecules ELFN1 and ELFN2.Mutations in ELFN1 and mGluRs were causally linked to rare neurodevelopmental disorder in humans featuring epilepsy and developmental delays. Other receptors that we study such as GABA(B) and mGlyR are also engaged in various extracellular interactions. Our model is that GPCRs in general may be guided by extracellular interactions that position them at the sites of the cognate transmitter release while providing allosteric control of their function. Surveying the landscape of these interactions, their functional roles, structural organization, and implications for physiology and behavior is our major emphasis.<\/p>\n\n\n\n<p class=\"has-white-color has-text-color has-link-color wp-elements-3 wp-block-paragraph\">space<\/p>\n<\/div>\n<\/div>\n\n\n\n<h3 class=\"wp-block-heading\" style=\"font-size:25px\"><strong><strong>Opioid signaling networks in substance use disorders<\/strong><\/strong><\/h3>\n\n\n\n<p class=\"has-medium-font-size wp-block-paragraph\">One of the most fundamental properties of receptor systems is their ability to scale signaling, depending on the input strength. For instance, strong and\/or prolonged activation of the GPCRs results in their desensitization manifesting as behavioral tolerance to stimulation. From the clinical perspective, this problem is particularly prominent with opioid analgesics used by millions of people for pain control. The euphoria produced by the opioid drugs that all act on their common target the GPCR, mu-opioid receptor (MOR), combined with the rapid development of tolerance fuels development of opioid misuse and overdose. There has been tremendous progress uncovering molecular underpinning of this process which resulted in identification of several GPCR regulators including GRK\/b-arrestin system, RGS and AGS proteins. Yet, there is a growing sense that significant portion of regulatory GPCR elements and principles remain in the dark as there has been virtually no systematic efforts to exhaustively profile such networks. <\/p>\n\n\n\n<p class=\"has-white-color has-text-color has-link-color wp-elements-4 wp-block-paragraph\">Space<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"302\" src=\"https:\/\/martemyanovlab.com\/wp-content\/uploads\/2026\/11\/beh_resp-1-1024x302.png\" alt=\"\" class=\"wp-image-4634\" srcset=\"https:\/\/martemyanovlab.com\/wp-content\/uploads\/2026\/11\/beh_resp-1-1024x302.png 1024w, https:\/\/martemyanovlab.com\/wp-content\/uploads\/2026\/11\/beh_resp-1-300x88.png 300w, https:\/\/martemyanovlab.com\/wp-content\/uploads\/2026\/11\/beh_resp-1-767x226.png 767w, https:\/\/martemyanovlab.com\/wp-content\/uploads\/2026\/11\/beh_resp-1-1140x335.png 1140w, https:\/\/martemyanovlab.com\/wp-content\/uploads\/2026\/11\/beh_resp-1-1536x452.png 1536w, https:\/\/martemyanovlab.com\/wp-content\/uploads\/2026\/11\/beh_resp-1.png 1840w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n\n\n<p class=\"has-white-color has-text-color has-link-color wp-elements-5 wp-block-paragraph\">Space<\/p>\n\n\n\n<p class=\"has-medium-font-size wp-block-paragraph\">In collaboration with Brock Grill (Seattle Children\u2019s) we have employed a forward genetic strategy performing genome-wide screen for modulators of GPCR responsiveness using animal behavior as a readout. We engineered the nematode <em>C. elegans<\/em> expressing MOR in its nervous system making the animals sensitive to opioid drugs. We then performed random chemical mutagenesis selecting mutant animals with altered opioid responsiveness. Causal genes were identified by next-generation sequencing and validated by target specific editing using CRISPR\/Cas9. Current list includes a diverse set of ~ 97 genes encoding putative enzymes, proteins with possible roles in degradation and trafficking, likely scaffolding proteins, cell-adhesion-like molecules and many proteins with completely unknown biology. We have validated several of them including prominent cholesterol regulator Ptchd1 and translated the findings to mouse models. We are currently studying function of several other identified regulators, their mechanistic role in GPCR signaling and contribution to behavioral effects of opioids.&nbsp;<\/p>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-7387b849 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:33.33%\">\n<p class=\"has-white-color has-text-color has-link-color has-medium-font-size wp-elements-6 wp-block-paragraph\">space<\/p>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:66.66%\"><\/div>\n<\/div>\n\n\n\n<h3 class=\"wp-block-heading\" style=\"font-size:25px\"><strong><strong>Leveraging unconventional biology of orphan receptors for neuropsychiatric disorders<\/strong><\/strong><\/h3>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"alignright size-full is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"854\" height=\"645\" src=\"https:\/\/martemyanovlab.com\/wp-content\/uploads\/2026\/11\/leveraging-1.png\" alt=\"\" class=\"wp-image-4583\" style=\"aspect-ratio:1.3240603580305808;width:459px;height:auto\" srcset=\"https:\/\/martemyanovlab.com\/wp-content\/uploads\/2026\/11\/leveraging-1.png 854w, https:\/\/martemyanovlab.com\/wp-content\/uploads\/2026\/11\/leveraging-1-300x227.png 300w, https:\/\/martemyanovlab.com\/wp-content\/uploads\/2026\/11\/leveraging-1-768x580.png 768w\" sizes=\"(max-width: 854px) 100vw, 854px\" \/><\/figure>\n<\/div>\n\n\n<p class=\"has-medium-font-size wp-block-paragraph\">Much of the research on GPCRs is focused on neurotransmitter receptors with conventional signaling properties. However, a significant fraction of GPCRs, the so-called \u2018orphan\u2019 receptors, remain poorly explored likely due to their unorthodox biology. While profiling gene and protein expression we found GPR158 to be one of the most abundant orphan GPCRs in the brain. It shows prominent regulation by maladaptive states such as exposure to stress and drugs. Notably, we found that GPR158 does not signal via heterotrimeric G proteins and instead links to an RGS complex, allosterically regulating its activity. Conceptually, this introduces a novel paradigm that orphan GPCRs can produce cellular response not only by activating G proteins but also by sending the opposite signal deactivating them. We have recently de-orphanized this receptor and found it to be a long-sought receptor for neurotransmitter glycine, prompting a new name for it: metabotropic glycine receptor (mGlyR). Genetic screening in <em>C. elegans<\/em> identified another orphan receptor: GPR139 as a potent suppressor of opioid effects. We have delineated its signaling mechanisms finding that it counteracts reactions initiated by canonical opioid receptors by engaging excitatory G protein Gaq and plays a role of homeostatic balancer adjusting the strength of the opioid signaling. Recently, we also de-orphanized it, discovering that it is liganded by the opioid peptide dynorphin making it a bona fide opioid receptor, thereby extending this receptor family by one more member. We are actively pursuing the biology of these receptors studying their role in shaping signaling cascades as well as behavioral implications. Further studies also focus on other poorly understood members of GPCR family including adhesion GPCRs and putative peptide receptors in synaptic physiology, circuit formation and behavior.<\/p>\n\n\n\n<p class=\"has-white-color has-text-color has-link-color wp-elements-7 wp-block-paragraph\">space<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n\n\n\n<h3 class=\"wp-block-heading\" style=\"font-size:25px\"><strong><strong>Building tools and approaches for deciphering GPCR signaling logic<\/strong><\/strong><\/h3>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"alignright size-full is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"606\" height=\"487\" src=\"https:\/\/martemyanovlab.com\/wp-content\/uploads\/2026\/11\/building.png\" alt=\"\" class=\"wp-image-4500\" style=\"width:499px;height:auto\" srcset=\"https:\/\/martemyanovlab.com\/wp-content\/uploads\/2026\/11\/building.png 606w, https:\/\/martemyanovlab.com\/wp-content\/uploads\/2026\/11\/building-300x241.png 300w\" sizes=\"(max-width: 606px) 100vw, 606px\" \/><\/figure>\n<\/div>\n\n\n<p class=\"has-medium-font-size wp-block-paragraph\">The laboratory is embarking on the challenge of understanding the complexity of GPCR-mediated signal conversion process <em>in vivo<\/em>. We have recently developed a \u201cmolecular dactyloscopy\u2019 platform for interrogating complexity of GPCR coupling to their G protein substrates, studying their pharmacological biases and relevance to neuropsychiatric disease affecting GPCR signaling systems. In this approach we measure the ability of GPCRs to activate their multiple G protein substrates in living cells using BRET-based real-time quantitative readout. We have found that GPCRs exhibit unique profiles of interactions with a gamut of Ga subunits, creating a characteristic \u201cfingerprint\u201d, which we think cells utilize for discriminating between individual commands encoded by messages. We are currently building comprehensive G protein specificity maps for all GPCRs, interrogating pharmacological biases of FDA approved GPCR drugs and studying pharmacogenomics aspects of GPCR variability in normal human population and pathological conditions. We have also developed an <em>in vivo<\/em> tool that allows monitoring signaling by many GPCRs by following their downstream effects on cAMP dynamics We are using this model to determine the integration of multiple concurrent inputs in intact neural circuits by imaging cAMP dynamics in response to optogenetically activating projections that release different neuromodulators (glutamate, GABA, acetylcholine), while blocking individual receptors pharmacologically and genetically.<\/p>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-7387b849 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:33.33%\">\n<p class=\"has-white-color has-text-color has-link-color has-medium-font-size wp-elements-8 wp-block-paragraph\">space<\/p>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:66.66%\"><\/div>\n<\/div>\n\n\n\n<h3 class=\"wp-block-heading\" style=\"font-size:25px\"><strong><strong><strong>Genetic Movement Disorders and Encephalopathies<\/strong><\/strong><\/strong><\/h3>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"alignright size-large is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"709\" src=\"https:\/\/martemyanovlab.com\/wp-content\/uploads\/2026\/11\/genetic-1024x709.png\" alt=\"\" class=\"wp-image-4501\" style=\"aspect-ratio:1.4443075069153453;width:539px;height:auto\" srcset=\"https:\/\/martemyanovlab.com\/wp-content\/uploads\/2026\/11\/genetic-1024x709.png 1024w, https:\/\/martemyanovlab.com\/wp-content\/uploads\/2026\/11\/genetic-300x208.png 300w, https:\/\/martemyanovlab.com\/wp-content\/uploads\/2026\/11\/genetic-767x531.png 767w, https:\/\/martemyanovlab.com\/wp-content\/uploads\/2026\/11\/genetic.png 1124w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n<\/div>\n\n\n<p class=\"has-medium-font-size wp-block-paragraph\">One of the key brain structures exquisitely relying on GPCR signaling is striatum, a nucleus involved in processing reward and movement-related decisions. Striatal medium spiny neurons (MSNs) process a staggering number of neurotransmitters inputs for which they utilize a number of GPCRs. However, they can discriminate between individual GPCR-mediated signals while adjusting sensitivity based on experience and demands with incredible plasticity to drive unique behaviors. The laboratory has a long-standing interest in dissecting intricacies of striatal neuromodulation. We have been defining new elements and regulatory principles of striatal GPCRs. We are characterizing the logic of connecting individual elements in the complex, their interplay and the functional consequences of disrupting interactions in the complex. Much of these studies are looking at the impact on generating a cAMP signal in parallel with analyzing behavioral responses of mice to drugs that influence processing of these signals, such as psychostimulants and opioids. In recent years, our research has shifted to dissecting molecular pathology associated with disruption in elements of the striatal GPCR signaling. Mutations in many of these genes has been causally linked to devastating pediatric encephalopathies prominently featuring movement issues. These prominently include mutations in G protein subunits: Gb1 (GNB1), Gb5 (GNB5), Gai1 (GNAI1) and Gao (GNAO1). We are actively researching the mechanisms by which these mutations cause disease, modeling them in reconstituted systems and generating and studying mouse models of these disorders.<\/p>\n\n\n\n<p class=\"has-white-color has-text-color has-link-color wp-elements-9 wp-block-paragraph\">space<\/p>\n\n\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-7387b849 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\"><\/div>\n<\/div>\n\n\n\n<h3 class=\"wp-block-heading\" style=\"font-size:25px\"><strong><strong><strong><strong>Development of small molecule probes and therapeutics<\/strong><\/strong><\/strong><\/strong><\/h3>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"alignleft size-large is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"1006\" src=\"https:\/\/martemyanovlab.com\/wp-content\/uploads\/2026\/11\/devel-1-1024x1006.png\" alt=\"\" class=\"wp-image-4584\" style=\"aspect-ratio:1.0179122915379863;width:413px;height:auto\" srcset=\"https:\/\/martemyanovlab.com\/wp-content\/uploads\/2026\/11\/devel-1-1024x1006.png 1024w, https:\/\/martemyanovlab.com\/wp-content\/uploads\/2026\/11\/devel-1-300x295.png 300w, https:\/\/martemyanovlab.com\/wp-content\/uploads\/2026\/11\/devel-1-768x754.png 768w, https:\/\/martemyanovlab.com\/wp-content\/uploads\/2026\/11\/devel-1-75x75.png 75w, https:\/\/martemyanovlab.com\/wp-content\/uploads\/2026\/11\/devel-1-1140x1119.png 1140w, https:\/\/martemyanovlab.com\/wp-content\/uploads\/2026\/11\/devel-1.png 1341w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n<\/div>\n\n\n<p class=\"has-medium-font-size wp-block-paragraph\">Identification and characterization of new GPCRs and regulators with links to neuropsychiatric conditions, substance use disorder, neurodevelopmental conditions, depression and anxiety provides ample opportunities for targeting them for therapeutic benefit. The laboratory is actively engaged in translational drug discovery efforts aimed at bringing next generation of therapeutics for ameliorating these grave conditions. We start by developing innovative assays, adapt them to the High Throughput Screening (HTS) format and identify small molecule leads through HTS campaigns. Our efforts are then focused on optimizing the molecules by means of medicinal chemistry to ensure their stability, brain penetration and in vivo efficacy. We rely on collaborative network for the efficient drug discovery pipeline with both academic and industrial partners. We are also developing biologics specifically engaging and locking GPCR targets (nanobodies) in specific states and are increasingly relying on computational and AI tools in the process. <\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n","protected":false},"excerpt":{"rendered":"<p>G Protein Coupled Receptors Signaling Systems The main emphasis of research in my laboratory is on understanding the fundamental principles of signal processing by G protein coupled receptor (GPCR) systems and their pharmacology and role in disease. GPCRs constitute the largest family of cell surface receptors in mammalian genomes, endowing cells with an ability to sense their environment and communicate with each other. Their evolutionary success is underscored by a wide spectrum of extracellular stimuli that they detect, including light, ions, hormones, and neurotransmitters, and their versatile signaling to a vast number of intracellular targets, such as enzymes, ion channels and transcription factors. Accordingly, dysfunctions in GPCR systems are linked to many diseases. Furthermore, altering the activity of GPCRs pharmacologically often produces clinically beneficial outcomes regardless of the disease origin, and GPCRs are targeted by ~50% of current drugs. Our research program is based on three pillars.First, we have fully embraced the power of unbiased approaches and utilize genomic and proteomic screens as a discovery methods of choice. This serves as the prime idea-generator for much of our hypothetical thinking about GPCR organizational principles. A decade of efforts in this area convinced us that there is much \u2018dark\u2019 biology, uncovering which can transform our views on how GPCRs work.Second, we are committed to studying pertinent questions in an endogenous setting using physiologically relevant in vivo models. We extensively rely on genetic mouse models specifically designed to manipulate with GPCR systems with cell type selectivity and temporal precision. The elements that we uncover in the unbiased screens are studied in respect to their role in mouse physiology and behavior. Third, we are very curious about detailed molecular mechanisms involved in operation of the GPCR complexes. We constantly develop tools and technologies for the interrogation of protein-protein interactions and signal transmission steps, harnessing power of optical sensors. We also increasingly rely on structural biology approaches to obtain atomic level details. This allows us to probe the nuts-and-bolts of GPCR function. space Vision, retina and photoreceptor synapses In the vertebrate retina communication of rod and cone photoreceptors with downstream ON bipolar neurons (ON-BC) is a critical point in the relay of a light stimulus to the brain. Here, light-induced changes in the release of neurotransmitter glutamate by photoreceptors are sensed by a GPCR, mGluR6, on postsynaptic ON-BCs. In addition to mediating synaptic communication with photoreceptors, mGluR6 is also essential for the physical synapse formation, a process that occurs with remarkable selectivity, such that ON-BCs discriminate between rods or cones. These features make photoreceptor synapses a convenient model for addressing many fundamental questions pertaining to spatio-temporal aspects of GPCR signaling and synaptic selectivity. Over the last several years, our laboratory substantially contributed to deciphering the molecular organization of this GPCR cascade while developing the \u2018signalosome\u2019 model. We are working to define the full composition and structure functional organization of the photoreceptor synaptic complex using a variety of approaches including electrophysiology, structural biology and biochemistry. We are also investigating cell biological mechanisms of photoreceptor wiring by defining synaptic selectivity code of photoreceptors by studying the role of newly identified cell adhesion molecules as we are also exploring general landscape of GPCR function in photoreceptors and other retina cell types. space Extracellular world of GPCRs and neurodevelopmental disorders The field has traditionally focused on cell-autonomous mechanisms of GPCR function, studying transducers of their signals, effector molecules and downstream regulators. Our proteomic profiling efforts led to an unexpected discovery that GPCRs also engage in extracellular interactions with cell-adhesion molecules that critically shape their function. We are particularly focused on the association of entire group III of metabotropic glutamate receptors (mGluR4, mGluR6, mGluR7 and mGluR8) the key presynaptic autoreceptors in the brain that regulate the release of main excitatory neurotransmitter glutamate, with cell adhesion molecules ELFN1 and ELFN2.Mutations in ELFN1 and mGluRs were causally linked to rare neurodevelopmental disorder in humans featuring epilepsy and developmental delays. Other receptors that we study such as GABA(B) and mGlyR are also engaged in various extracellular interactions. Our model is that GPCRs in general may be guided by extracellular interactions that position them at the sites of the cognate transmitter release while providing allosteric control of their function. Surveying the landscape of these interactions, their functional roles, structural organization, and implications for physiology and behavior is our major emphasis. space Opioid signaling networks in substance use disorders One of the most fundamental properties of receptor systems is their ability to scale signaling, depending on the input strength. For instance, strong and\/or prolonged activation of the GPCRs results in their desensitization manifesting as behavioral tolerance to stimulation. From the clinical perspective, this problem is particularly prominent with opioid analgesics used by millions of people for pain control. The euphoria produced by the opioid drugs that all act on their common target the GPCR, mu-opioid receptor (MOR), combined with the rapid development of tolerance fuels development of opioid misuse and overdose. There has been tremendous progress uncovering molecular underpinning of this process which resulted in identification of several GPCR regulators including GRK\/b-arrestin system, RGS and AGS proteins. Yet, there is a growing sense that significant portion of regulatory GPCR elements and principles remain in the dark as there has been virtually no systematic efforts to exhaustively profile such networks. Space Space In collaboration with Brock Grill (Seattle Children\u2019s) we have employed a forward genetic strategy performing genome-wide screen for modulators of GPCR responsiveness using animal behavior as a readout. We engineered the nematode C. elegans expressing MOR in its nervous system making the animals sensitive to opioid drugs. We then performed random chemical mutagenesis selecting mutant animals with altered opioid responsiveness. Causal genes were identified by next-generation sequencing and validated by target specific editing using CRISPR\/Cas9. Current list includes a diverse set of ~ 97 genes encoding putative enzymes, proteins with possible roles in degradation and trafficking, likely scaffolding proteins, cell-adhesion-like molecules and many proteins with completely unknown biology. We have validated several of them including prominent cholesterol regulator Ptchd1 and translated the findings to mouse models. We are currently studying function of several other identified regulators, their mechanistic role in GPCR signaling and contribution to behavioral effects of opioids.&nbsp; space Leveraging unconventional biology of orphan receptors for neuropsychiatric disorders Much of the research on GPCRs is focused on neurotransmitter receptors with conventional signaling properties. However, a significant fraction of GPCRs, the so-called \u2018orphan\u2019 receptors, remain poorly explored likely due to their unorthodox biology. While profiling gene and protein expression we found GPR158 to be one of the most abundant orphan GPCRs in the brain. It shows prominent regulation by maladaptive states such as exposure to stress and drugs. Notably, we found that GPR158 does not signal via heterotrimeric G proteins and instead links to an RGS complex, allosterically regulating its activity. Conceptually, this introduces a novel paradigm that orphan GPCRs can produce cellular response not only by activating G proteins but also by sending the opposite signal deactivating them. We have recently de-orphanized this receptor and found it to be a long-sought receptor for neurotransmitter glycine, prompting a new name for it: metabotropic glycine receptor (mGlyR). Genetic screening in C. elegans identified another orphan receptor: GPR139 as a potent suppressor of opioid effects. We have delineated its signaling mechanisms finding that it counteracts reactions initiated by canonical opioid receptors by engaging excitatory G protein Gaq and plays a role of homeostatic balancer adjusting the strength of the opioid signaling. Recently, we also de-orphanized it, discovering that it is liganded by the opioid peptide dynorphin making it a bona fide opioid receptor, thereby extending this receptor family by one more member. We are actively pursuing the biology of these receptors studying their role in shaping signaling cascades as well as behavioral implications. Further studies also focus on other poorly understood members of GPCR family including adhesion GPCRs and putative peptide receptors in synaptic physiology, circuit formation and behavior. space Building tools and approaches for deciphering GPCR signaling logic The laboratory is embarking on the challenge of understanding the complexity of GPCR-mediated signal conversion process in vivo. We have recently developed a \u201cmolecular dactyloscopy\u2019 platform for interrogating complexity of GPCR coupling to their G protein substrates, studying their pharmacological biases and relevance to neuropsychiatric disease affecting GPCR signaling systems. In this approach we measure the ability of GPCRs to activate their multiple G protein substrates in living cells using BRET-based real-time quantitative readout. We have found that GPCRs exhibit unique profiles of interactions with a gamut of Ga subunits, creating a characteristic \u201cfingerprint\u201d, which we think cells utilize for discriminating between individual commands encoded by messages. We are currently building comprehensive G protein specificity maps for all GPCRs, interrogating pharmacological biases of FDA approved GPCR drugs and studying pharmacogenomics aspects of GPCR variability in normal human population and pathological conditions. We have also developed an in vivo tool that allows monitoring signaling by many GPCRs by following their downstream effects on cAMP dynamics We are using this model to determine the integration of multiple concurrent inputs in intact neural circuits by imaging cAMP dynamics in response to optogenetically activating projections that release different neuromodulators (glutamate, GABA, acetylcholine), while blocking individual receptors pharmacologically and genetically. space Genetic Movement Disorders and Encephalopathies One of the key brain structures exquisitely relying on GPCR signaling is striatum, a nucleus involved in processing reward and movement-related decisions. Striatal medium spiny neurons (MSNs) process a staggering number of neurotransmitters inputs for which they utilize a number of GPCRs. However, they can discriminate between individual GPCR-mediated signals while adjusting sensitivity based on experience and demands with incredible plasticity to drive unique behaviors. The laboratory has a long-standing interest in dissecting intricacies of striatal neuromodulation. We have been defining new elements and regulatory principles of striatal GPCRs. We are characterizing the logic of connecting individual elements in the complex, their interplay and the functional consequences of disrupting interactions in the complex. Much of these studies are looking at the impact on generating a cAMP signal in parallel with analyzing behavioral responses of mice to drugs that influence processing of these signals, such as psychostimulants and opioids. In recent years, our research has shifted to dissecting molecular pathology associated with disruption in elements of the striatal GPCR signaling. Mutations in many of these genes has been causally linked to devastating pediatric encephalopathies prominently featuring movement issues. These prominently include mutations in G protein subunits: Gb1 (GNB1), Gb5 (GNB5), Gai1 (GNAI1) and Gao (GNAO1). We are actively researching the mechanisms by which these mutations cause disease, modeling them in reconstituted systems and generating and studying mouse models of these disorders. space Development of small molecule probes and therapeutics Identification and characterization of new GPCRs and regulators with links to neuropsychiatric conditions, substance use disorder, neurodevelopmental conditions, depression and anxiety provides ample opportunities for targeting them for therapeutic benefit. The laboratory is actively engaged in translational drug discovery efforts aimed at bringing next generation of therapeutics for ameliorating these grave conditions. We start by developing innovative assays, adapt them to the High Throughput Screening (HTS) format and identify small molecule leads through HTS campaigns. Our efforts are then focused on optimizing the molecules by means of medicinal chemistry to ensure their stability, brain penetration and in vivo efficacy. We rely on collaborative network for the efficient drug discovery pipeline with both academic and industrial partners. We are also developing biologics specifically engaging and locking GPCR targets (nanobodies) in specific states and are increasingly relying on computational and AI tools in the process.<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-30","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/martemyanovlab.com\/index.php\/wp-json\/wp\/v2\/pages\/30","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/martemyanovlab.com\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/martemyanovlab.com\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/martemyanovlab.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/martemyanovlab.com\/index.php\/wp-json\/wp\/v2\/comments?post=30"}],"version-history":[{"count":301,"href":"https:\/\/martemyanovlab.com\/index.php\/wp-json\/wp\/v2\/pages\/30\/revisions"}],"predecessor-version":[{"id":4637,"href":"https:\/\/martemyanovlab.com\/index.php\/wp-json\/wp\/v2\/pages\/30\/revisions\/4637"}],"wp:attachment":[{"href":"https:\/\/martemyanovlab.com\/index.php\/wp-json\/wp\/v2\/media?parent=30"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}